These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20119823)

  • 1. Neuroprotective effect of carvedilol and melatonin on 3-nitropropionic acid-induced neurotoxicity in neuroblastoma.
    Tasset I; Espínola C; Medina FJ; Feijóo M; Ruiz C; Moreno E; Gómez MM; Collado JA; Muñoz C; Muntané J; Montilla P; Túnez I
    J Physiol Biochem; 2009 Sep; 65(3):291-6. PubMed ID: 20119823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of carvedilol on oxidative stress induced by okadaic acid in N1E-115 cells.
    Túnez I; Collado JA; Medina FJ; Muñoz MC; Gordillo R; Sampedro C; Moyano MJ; Feijóo M; Muntané J; Montilla P
    Pharmacol Res; 2006 Sep; 54(3):241-6. PubMed ID: 16829126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged pretreatment with carvedilol prevents 3-nitropropionic acid-induced behavioral alterations and oxidative stress in rats.
    Kumar P; Kumar A
    Pharmacol Rep; 2008; 60(5):706-15. PubMed ID: 19066418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cells.
    Yue TL; Mckenna PJ; Gu JL; Cheng HY; Ruffolo RR; Feuerstein GZ
    Hypertension; 1993 Dec; 22(6):922-8. PubMed ID: 7902335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome.
    Singh A; Naidu PS; Gupta S; Kulkarni SK
    J Med Food; 2002; 5(4):211-20. PubMed ID: 12639396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary artery disease and antioxidants--is there a role for carvedilol?
    Landray MJ; Kendall MJ
    J Clin Pharm Ther; 1997 Feb; 22(1):3-5. PubMed ID: 9292396
    [No Abstract]   [Full Text] [Related]  

  • 7. Carvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status. A comparative study of two beta-blocking drugs, carvedilol and propanolol.
    Van den Branden C; Gabriels M; Vamecq J; Vanden Houte K; Verbeelen D
    Nephron; 1997; 77(3):319-24. PubMed ID: 9375827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of antioxidants in chronic fatigue syndrome in mice.
    Singh A; Garg V; Gupta S; Kulkarni SK
    Indian J Exp Biol; 2002 Nov; 40(11):1240-4. PubMed ID: 13677625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olive oil reduces oxidative damage in a 3-nitropropionic acid-induced Huntington's disease-like rat model.
    Tasset I; Pontes AJ; Hinojosa AJ; de la Torre R; Túnez I
    Nutr Neurosci; 2011 May; 14(3):106-11. PubMed ID: 21756531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin prevents cytoskeletal alterations and oxidative stress induced by okadaic acid in N1E-115 cells.
    Benitez-King G; Túnez I; Bellon A; Ortíz GG; Antón-Tay F
    Exp Neurol; 2003 Jul; 182(1):151-9. PubMed ID: 12821385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of neurosteroids in experimental 3-nitropropionic acid induced neurotoxicity in rats.
    Kumar P; Kumar P; Khan A; Deshmukh R; Lal Sharma P
    Eur J Pharmacol; 2014 Jan; 723():38-45. PubMed ID: 24333475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease.
    Túnez I; Montilla P; Del Carmen Muñoz M; Feijóo M; Salcedo M
    J Pineal Res; 2004 Nov; 37(4):252-6. PubMed ID: 15485551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effect of carvedilol against aluminium induced toxicity: possible behavioral and biochemical alterations in rats.
    Kumar A; Prakash A; Dogra S
    Pharmacol Rep; 2011; 63(4):915-23. PubMed ID: 22001979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hydroxylated analog of the beta-adrenoceptor antagonist, carvedilol, affords exceptional antioxidant protection to postischemic rat hearts.
    Kramer JH; Weglicki WB
    Free Radic Biol Med; 1996; 21(6):813-25. PubMed ID: 8902527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chronic treatment of carvedilol on oxidative stress in an intracerebroventricular streptozotocin induced model of dementia in rats.
    Prakash AK; Kumar A
    J Pharm Pharmacol; 2009 Dec; 61(12):1665-72. PubMed ID: 19958590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.
    Ruffolo RR; Feuerstein GZ
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():247-56. PubMed ID: 9211017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carvedilol and trimetazidine attenuates ferric nitrilotriacetate-induced oxidative renal injury in rats.
    Singh D; Chander V; Chopra K
    Toxicology; 2003 Sep; 191(2-3):143-51. PubMed ID: 12965117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carvedilol treatment ameliorates acute coxsackievirus B3-induced myocarditis associated with oxidative stress reduction.
    Li YC; Ge LS; Yang PL; Tang JF; Lin JF; Chen P; Guan XQ
    Eur J Pharmacol; 2010 Aug; 640(1-3):112-6. PubMed ID: 20457150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effect of carvedilol, an adrenergic antagonist against colchicine induced cognitive impairment and oxidative damage in rat.
    Kumar A; Dogra S
    Pharmacol Biochem Behav; 2009 Mar; 92(1):25-31. PubMed ID: 18992766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvedilol decreases elevated oxidative stress in human failing myocardium.
    Nakamura K; Kusano K; Nakamura Y; Kakishita M; Ohta K; Nagase S; Yamamoto M; Miyaji K; Saito H; Morita H; Emori T; Matsubara H; Toyokuni S; Ohe T
    Circulation; 2002 Jun; 105(24):2867-71. PubMed ID: 12070115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.